2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindoline-5-carbaldehyde, 98%, 250mg

Éter monopropílico de dipropilenglicol, min 98%, para síntesis, 1L, envase de plástico.

3-Amino-5-hydroxypyridine, 98.0%, 250mg

6-Bromo-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene, 97.0%, 25g

4-CHLORO-6-(METHYLTHIO)-1H-PYRAZOLO[3,4-D]PYRIMIDINE, 95%, 100mg

TERT-BUTYL (1-(4-HYDROXYPHENYL)ETHYL)CARBAMATE, 95.0%, 250mg

8-chloro-4-phenylsulfanyl-1-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline, 97%, 100mg

(R)-tert-Butyl ((4,4-difluoropyrrolidin-2-yl)methyl)carbamate, 95.0%, 250mg

N-Methyl-N-phenethyl-2-phenylethanamine, 95.0%, 1g

ETHYL 1'-AMINO-[1,1'-BI(CYCLOPROPANE)]-1-CARBOXYLATE HCL, 95.0%, 250mg

2,4,6-Tri([1,1'-biphenyl]-4-yl)-1,3,5-triazine, 97%, 10g

[1-(aminomethyl)cyclopropyl]acetic acid hydrochloride, 95.0%, 250mg

3,5-Difluoro-4-iodo-pyridine, 98.0%, 1g